News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Keeping stomach cancer at bay
Researchers have identified a protein in immune cells that may play a role in thwarting a type of stomach cancer, paving the way for possible prevention therapies.… Read more
-
Simple blood test can improve ovarian cancer diagnosis
Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer.… Read more
-
Gut bacteria and the immune system—mapping out interactions
Hudson Institute scientists Dr Emily Gulliver and Dr Sam Forster were part of a leading collaborative study with the Wellcome Sanger Institute, which created the first detailed cell atlas of immune cells and gut bacteria within the human colon.… Read more
-
Unearthing a new form of toxic inflammation
Hudson Institute scientists have discovered how a molecule is transferred between damaged cells and healthy immune cells, which might cause toxic inflammation in a host of diseases.… Read more
-
Treating UTIs—where to from here
The discovery that the bladder isn’t sterile has opened up new avenues of treatment for urinary tract infections (UTI).… Read more
-
Strengthening international collaborations with the University of Toronto
A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto.… Read more
-
Cancer Council Victoria Postdoctoral Fellowship awarded to progress lung cancer research
Congratulations to Dr Mohamed Saad, who has been awarded a Cancer Council Victoria (CCV) Postdoctoral Cancer Research Fellowship to inform the design of better treatment approaches in lung cancer.… Read more
-
Celebrating a successful Rebecca L Cooper Foundation Grant
Congratulations to Dr Gina Kusuma, who has been awarded a two-year Rebecca L Cooper Medical Research Foundation Project Grant to investigate cell-free therapeutics which can mediate vascular regeneration in the aged population.… Read more
-
Paving the way towards a new anti-inflammatory agent
Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.… Read more
-
Congratulations to our CASS Foundation grant awardees
Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary aldosteronism and endometriosis in 2020.… Read more
